Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ann Surg Oncol. 2019 Feb;26(2):593-603. doi: 10.1245/s10434-018-6830-x. Epub 2018 Nov 27.
The aim of this study was to examine if the prognostic significance of margin status in hepatectomy for colorectal cancer liver metastasis (CRLM) varies for different levels of tumor burden because hepatectomy indications for CRLM have been recently expanded to include patients with a higher tumor burden in whom achieving an R0 resection is difficult.
Clinicopathological variables in an exploration cohort of 290 patients receiving hepatectomy in Japan for CRLM were investigated. R0 resection was defined as a margin width > 0 mm. Tumor burden was assessed using the recently introduced Tumor Burden Score (TBS), which was calculated as TBS = (maximum tumor diameter in cm) + (number of lesions). The principal findings were validated using a cohort from the United States.
R1 resection rates significantly increased as TBS increased: 4/86 (4.7%) in patients with TBS < 3, 29/171 (17.0%) in patients with TBS ≥ 3 and < 9, and 9/33 (27.3%) in patients with TBS ≥ 9 (p < 0.001). R0 resection was significantly superior to R1 resection in patients with TBS ≥ 5; however, this was not the case for TBS ≥ 6, as confirmed by both univariate and multivariate analyses. Furthermore, prehepatectomy chemotherapy was associated with significantly improved survival for patients with TBS ≥ 8. Analysis of the validation cohort yielded similar results.
R0 resection appeared to have a positive impact on prognosis among patients with low tumor burden; however, this was not the case for patients with high tumor burden. As such, systemic treatment, in addition to surgery, may be central to achieving satisfactory outcomes in the latter patient population.
本研究旨在探讨在结直肠癌肝转移(CRLM)患者的肝切除术中,切缘状态的预后意义是否因肿瘤负荷水平而异,因为肝切除的适应证最近已扩展到包括肿瘤负荷较高且难以实现 R0 切除的患者。
对在日本接受肝切除术治疗 CRLM 的 290 例患者的临床病理变量进行了探索性队列研究。R0 切除定义为切缘宽度>0mm。肿瘤负荷采用最近提出的肿瘤负担评分(TBS)进行评估,其计算方法为 TBS=(最大肿瘤直径 cm)+(病灶数)。使用来自美国的队列对主要发现进行了验证。
随着 TBS 的增加,R1 切除率显著增加:TBS<3 的患者中为 4/86(4.7%),TBS≥3 且<9 的患者中为 29/171(17.0%),TBS≥9 的患者中为 9/33(27.3%)(p<0.001)。TBS≥5 的患者中,R0 切除明显优于 R1 切除;然而,通过单变量和多变量分析,TBS≥6 的情况并非如此。此外,术前化疗与 TBS≥8 的患者的生存显著改善相关。验证队列的分析得出了类似的结果。
对于低肿瘤负荷的患者,R0 切除似乎对预后有积极影响;然而,对于高肿瘤负荷的患者则不然。因此,除了手术之外,系统治疗可能是后者患者群体获得满意结果的关键。